BioMarin
BioMarin Pharmaceutical Inc. is a world leader in developing and commercializing innovative therapies for rare genetic diseases. As pioneers of breakthrough medicines, we focus on patients facing rare and sometimes fatal conditions who have limited, if any, treatment options. With seven products on the market and multiple clinical and pre-clinical product candidates, BioMarin is dedicated to providing innovative therapeutics to patients with serious unmet medical needs.
Joyanna Hansen: A Journey from the Clinic to BioMarin
Camp Ellellbee Creates Space for Connection, Joy and Open Conversations About Skeletal Conditions
Finding Community: Raegan and Raechel’s Journey with Achondroplasia and Experience at Camp Ellellbee
Christina Pao on Charting a New Course for Children with Hypochondroplasia
Signature Science: Javier Femenia Helps Turn Promising Molecules into Breakthrough Medicines
Campfires and Connections: How Summer Camp Brings Families with PKU Together
Living the BioMarin 8
The BioMarin 8: Operating Principles That Guide Our Work
Perseverance and Positivity: Chris’s Journey with MPS IVA
From Diagnosis to Advocacy: Kristin's Story
Hope for a Brighter Future: Kainen's Story
'Her Future is in Her Own Hands': KK's Journey with Achondroplasia
Commitment to Patients: Kendra's Story
Brett Crawford: Art & Science
Meet Kevin Eggan
Meet Greg Guyer
Free To Be Me
2022 Love Lock Ceremony
Bone Growth in Achondroplasia
Meet Sylvia Fong
The Pursuit of PKU
Rare Disease Day 2021: Trees of Life Love Lock Ceremony
How mutations, or variations, can lead to genetic conditions
The Making of Hemophilia: the Musical
Live Performance of Hemophilia: the Musical
Finding Tomorrows Trailer
Finding Tomorrows: Full Film